Tipifarnib

Tipifarnib is a nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction. By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Zarnestra and tipifarnibum. Its PubChem CID is 159324.

CAS No 192185-72-1
Molecular Formula C27H22Cl2N4O
Molecular Weight 489.4 g/mol
Synonyms 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one

Frequently Asked Questions